Salvage Surgery Following Downstaging of Unresectable Hepatocellular Carcinoma—A Strategy to Increase Resectability
- 22 September 2007
- journal article
- review article
- Published by Springer Science and Business Media LLC in Annals of Surgical Oncology
- Vol. 14 (12), 3301-3309
- https://doi.org/10.1245/s10434-007-9549-7
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- A Randomized Phase III Study of Doxorubicin Versus Cisplatin/Interferon α-2b/Doxorubicin/Fluorouracil (PIAF) Combination Chemotherapy for Unresectable Hepatocellular CarcinomaJNCI Journal of the National Cancer Institute, 2005
- Systemic Therapy for Colorectal CancerNew England Journal of Medicine, 2005
- Tumor Progression While on ChemotherapyAnnals of Surgery, 2004
- Systemic therapy for advanced hepatocellular carcinoma: a reviewEuropean Journal Of Cancer, 2004
- Risk-adapted treatment for childhood hepatoblastoma: final report of the second study of the International Society of Paediatric Oncology—SIOPEL 2European Journal Of Cancer, 2004
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalHepatology, 2003
- Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastomaEuropean Journal Of Cancer, 1997
- Resection of Nonresectable Liver Metastases from Colorectal Cancer After Neoadjuvant ChemotherapyAnnals of Surgery, 1996
- Resection of colorectal liver metastasesWorld Journal of Surgery, 1995
- Preoperative chemotherapy in ‘Unresectable’ hepatoblastomaJournal of Pediatric Surgery, 1989